Company news

United Therapeutics Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application

October 17, 2021

United Therapeutics to Present New Data at CHEST Annual Meeting 2021

October 10, 2021

United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval

September 29, 2021

United Therapeutics Releases its Annual Corporate Responsibility Report

September 9, 2021

United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021

September 6, 2021

United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month

August 24, 2021

United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021

August 23, 2021

United Therapeutics Corporation Reports Second Quarter 2021 Financial Results

August 3, 2021

United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference

August 2, 2021

United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021

July 27, 2021

United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study

June 29, 2021

United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review

June 15, 2021

MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA

June 15, 2021

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

June 6, 2021

United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis

June 2, 2021

United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference

May 24, 2021

United Therapeutics Corporation Reports First Quarter 2021 Financial Results

May 4, 2021

United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021

April 25, 2021

United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA

April 18, 2021

Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA

April 18, 2021

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

March 31, 2021

United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum

March 23, 2021

United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference

March 8, 2021

United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care Conference

February 23, 2021

United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results

February 23, 2021

United Therapeutics Corporation To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021

February 16, 2021

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®

February 9, 2021

United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI™ Meets Primary Objective

January 27, 2021

3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative

January 26, 2021

United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease

January 12, 2021

United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference

January 3, 2021

United Therapeutics Announces Agreement To Acquire Priority Review Voucher

December 27, 2020

United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis

December 8, 2020

United Therapeutics Releases Its First Corporate Responsibility Report

November 23, 2020

United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference

November 9, 2020

United Therapeutics Corporation To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference

November 1, 2020

United Therapeutics Corporation Reports Third Quarter 2020 Financial Results

October 27, 2020

United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting

October 21, 2020

United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020

October 20, 2020

United Therapeutics to Present New Tyvaso® Clinical and Treprostinil Real-World Data at CHEST Annual Meeting 2020

October 14, 2020

CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant

September 20, 2020

United Therapeutics Corporation to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 15, 2020

United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors

September 10, 2020

United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease

August 16, 2020

United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual Conference

August 4, 2020

United Therapeutics Corporation Reports Second Quarter 2020 Financial Results

July 28, 2020

United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia

July 22, 2020

United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020

July 21, 2020

United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session

June 16, 2020

United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

June 4, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 22 decks. Every deck is listed under its year.